Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7159 p139-143
4 August 2001

This article
Reprint
Photocopy


News summary


Self-treatment of UTIs safe and feasible

Self-diagnosis and self-treatment with antimicrobials of urinary tract infection (UTI) in women with recurrent infections is safe and feasible, researchers have found.

Dr Kalapna Gupta and colleagues from the University of Washington, Seattle, investigated the feasibility of patient-initiated treatment of UTIs in 172 young women. All had had at least two UTIs in the previous 12 months.

Management of recurrent UTI is commonly based on use of low-dose antimicrobial prophylaxis. However, variability in the number of recurrences means that continuous prophylaxis can result in unnecessary antimicrobial use, they say.

After self-diagnosing a UTI, women in the study collected a urine sample before commencing a three-day course of either ofloxacin or levofloxacin that they were given at the start of the study. Presence of infection was determined by tests on the urine sample.

The women were followed up for between two and 12 months (mean eight months). During the study, 88 women self-diagnosed a total of 172 infections. Mild genitourinary symptoms that were not considered indicative of UTI were reported by 64 women. Of 169 episodes where antimicrobial therapy was initiated, 94 per cent (95 per cent confidence interval, 90 to 99 per cent) of infections were microbiologically confirmed.

Clinical cure of infection was observed in 92 per cent of cases and only 6 per cent of women ultimately required antimicrobial prophylaxis for management of recurrent infection. In addition, 84 of the 172 women did not have an infection during the study. The authors conclude that self-diagnosis and self-treatment “greatly reduced the overall antibiotic usage that would have occurred if prophylaxis was routinely prescribed to all study women”. However, they caution that the approach should only be used for women with uncomplicated UTIs who could accurately follow the study protocol.

Patient satisfaction was high. Women reported that they were comfortable with the process of self-diagnosis and self-treatment, that they could start therapy earlier and that they had a shorter duration of symptoms compared with previous episodes of UTI managed traditionally (ie, by consulting a health care provider before starting therapy).
(Annals of Internal Medicine 2001; 135:9.)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal